Lyme2miami Limited - Accounts to registrar (filleted) - small 18.2

Lyme2miami Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v22.1.4.3 11355374 director 1.1.21 31.3.22 31.3.22 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure113553742020-12-31113553742022-03-31113553742021-01-012022-03-31113553742019-12-31113553742020-01-012020-12-31113553742020-12-3111355374ns16:EnglandWales2021-01-012022-03-3111355374ns15:PoundSterling2021-01-012022-03-3111355374ns11:Director12021-01-012022-03-3111355374ns11:PrivateLimitedCompanyLtd2021-01-012022-03-3111355374ns11:SmallEntities2021-01-012022-03-3111355374ns11:AuditExempt-NoAccountantsReport2021-01-012022-03-3111355374ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012022-03-3111355374ns11:SmallCompaniesRegimeForAccounts2021-01-012022-03-3111355374ns11:FullAccounts2021-01-012022-03-3111355374ns11:RegisteredOffice2021-01-012022-03-3111355374ns6:ShareCapital2022-03-3111355374ns6:ShareCapital2020-12-3111355374ns6:RetainedEarningsAccumulatedLosses2022-03-3111355374ns6:RetainedEarningsAccumulatedLosses2020-12-3111355374ns6:CostValuation2020-12-3111355374ns6:DisposalsRepaymentsInvestments2022-03-3111355374ns6:CostValuation2022-03-3111355374ns6:AdditionsToInvestments2022-03-31
REGISTERED NUMBER: 11355374 (England and Wales)















Unaudited Financial Statements

for the Period 1 January 2021 to 31 March 2022

for

Lyme2miami Limited

Lyme2miami Limited (Registered number: 11355374)






Contents of the Financial Statements
for the Period 1 January 2021 to 31 March 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Lyme2miami Limited

Company Information
for the Period 1 January 2021 to 31 March 2022







DIRECTOR: J Gorfin





REGISTERED OFFICE: The Dormers
2 Low Road
Congham
King's Lynn
Norfolk
PE32 1AE





REGISTERED NUMBER: 11355374 (England and Wales)





ACCOUNTANTS: Pareto Tax & Wealth LLP
Level 7, Tower 12,
18-22 Bridge Street,
Spinningfields,
Manchester
M3 3BZ

Lyme2miami Limited (Registered number: 11355374)

Balance Sheet
31 March 2022

31.3.22 31.12.20
Notes £    £    £    £   
FIXED ASSETS
Investments 4 4,910,118 3,711,840

CURRENT ASSETS
Cash at bank 138 400
NET CURRENT ASSETS 138 400
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,910,256

3,712,240

CAPITAL AND RESERVES
Called up share capital 4,746 4,746
Retained earnings 4,905,510 3,707,494
SHAREHOLDERS' FUNDS 4,910,256 3,712,240

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 June 2022 and were signed by:





J Gorfin - Director


Lyme2miami Limited (Registered number: 11355374)

Notes to the Financial Statements
for the Period 1 January 2021 to 31 March 2022

1. STATUTORY INFORMATION

Lyme2miami Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2020 - NIL).

4. FIXED ASSET INVESTMENTS

31.3.22 31.12.20
£    £   
Shares in group undertakings 80 4,626
Loans to group undertakings 3,700,763 2,497,939
Other loans 1,209,275 1,209,275
4,910,118 3,711,840

Lyme2miami Limited (Registered number: 11355374)

Notes to the Financial Statements - continued
for the Period 1 January 2021 to 31 March 2022

4. FIXED ASSET INVESTMENTS - continued

Additional information is as follows:
Shares in
group
undertakings
£   
COST
At 1 January 2021 4,626
Disposals (4,546 )
At 31 March 2022 80
NET BOOK VALUE
At 31 March 2022 80
At 31 December 2020 4,626
Loans to
group Other
undertakings loans Totals
£    £    £   
At 1 January 2021 2,497,939 1,209,275 3,707,214
New in year 1,203,115 - 1,203,115
Repayment in year (291 ) - (291 )
At 31 March 2022 3,700,763 1,209,275 4,910,038

At 31 March 2022 the company owned 100% of the share capital in Lyme2miami Inc.